193 related articles for article (PubMed ID: 26049070)
1. The Fibrinolytic Status in Liver Diseases.
Leebeek FW; Rijken DC
Semin Thromb Hemost; 2015 Jul; 41(5):474-80. PubMed ID: 26049070
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
Matsuura R; Soma M; Maeda Y; Kasakura S
Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
[TBL] [Abstract][Full Text] [Related]
3. Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis.
Gitto S; Romanelli RG; Cellai AP; Lami D; Vizzutti F; Abbate R; Margheri F; Fibbi G; Del Rosso M; Laffi G
Intern Emerg Med; 2021 Mar; 16(2):339-347. PubMed ID: 32445164
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
[TBL] [Abstract][Full Text] [Related]
5. Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation.
Segal H; Cottam S; Potter D; Hunt BJ
Hepatology; 1997 Mar; 25(3):683-8. PubMed ID: 9049219
[TBL] [Abstract][Full Text] [Related]
6. Hyperfibrinolysis in liver disease.
Ferro D; Celestini A; Violi F
Clin Liver Dis; 2009 Feb; 13(1):21-31. PubMed ID: 19150306
[TBL] [Abstract][Full Text] [Related]
7. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
[TBL] [Abstract][Full Text] [Related]
8. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
Violi F; Ferro D
Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests.
Rijken DC; Kock EL; Guimarães AH; Talens S; Darwish Murad S; Janssen HL; Leebeek FW
J Thromb Haemost; 2012 Oct; 10(10):2116-22. PubMed ID: 22906184
[TBL] [Abstract][Full Text] [Related]
10. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
11. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
Agarwal S; Joyner KA; Swaim MW
Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
[TBL] [Abstract][Full Text] [Related]
12. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.
Roullet S; Labrouche S; Mouton C; Quinart A; Nouette-Gaulain K; Laurent C; Freyburger G
J Clin Pathol; 2019 Jan; 72(1):58-65. PubMed ID: 30282673
[TBL] [Abstract][Full Text] [Related]
13. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
14. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor.
Hersch SL; Kunelis T; Francis RB
Blood; 1987 May; 69(5):1315-9. PubMed ID: 2436684
[TBL] [Abstract][Full Text] [Related]
17. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
[TBL] [Abstract][Full Text] [Related]
18. [Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
Pósán E; Tornai I; Udvardy M
Orv Hetil; 1994 Dec; 135(51):2821-4. PubMed ID: 7838517
[TBL] [Abstract][Full Text] [Related]
19. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
[TBL] [Abstract][Full Text] [Related]
20. Hemostasis and global fibrinolytic capacity in chronic liver disease.
Aytac S; Turkay C; Bavbek N; Kosar A
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):623-6. PubMed ID: 17890949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
